Table 3. Specimen CEC cellularity by diagnostic grouping.

	n(%)
Malignant <10 cells	24 (26.7%)
Malignant 10-100 cells	40 (44.4%)
Malignant >100 cells	17 (18.9%)
Malignant Naked Nuclei only	9 (10.0%)
Benign <10 cells	7 (28.0%)
Benign 10-100 cells	11 (44.0%)
Benign >100 cells	6 (24.0%)
Benign Naked Nuclei only	1 (4.0%)
p-value = 0.85
Neoplastic <10 cells	28 (26.4%)
Neoplastic 10-100 cells	48 (45.3%)
Neoplastic >100 cells	21 (19.8%)
Neoplastic Naked Nuclei only	9 (8.5%)
Non-Neoplastic <10 cells	3 (33.3%)
Non-Neoplastic 10-100 cells	3 (33.3%)
Non-Neoplastic >100 cells	2 (22.2%)
Non-Neoplastic Naked Nuclei only	1 (11.1%)
p-value = 0.77
PDAC <10 cells	22 (30.6%)
PDAC 10-100 cells	30 (41.7%)
PDAC >100 cells	13 (18.1%)
PDAC Naked Nuclei only	7 (9.7%)
NET <10 cells	1 (12.5%)
NET 10-100 cells	2 (25.0%)
NET >100 cells	3 (37.5%)
NET Naked Nuclei only	2 (25.0%)
p-value = 0.22

CEC: Circulating epithelioid cells. PDAC: Pancreatic ductal adenocarcinoma. NET: Neuroendocrine tumor.